Investor Presentation - First Six Months of 2021

21 Investor presentation First six months of 2021 Diabetes care Strengthen leadership by offering innovative medicines and driving patient outcomes Novo Nordisk Way Biopharm Secure a leading position by leveraging full portfolio and expanding into adjacent areas Driving change to defeat diabetes and other serious chronic diseases Sustainable business PR Obesity care Strengthen treatment options through market development and by offering innovative medicines and driving patient outcomes Other serious chronic diseases Establish presence by building competitive pipeline and scientific leadership

View entire presentation